LFTD Partners Inc. (LIFD) stock
LIFDOTCPharmaceutical PreparationsFiscal year ends December 31
$0.10+0.00 (0.00%)
Close on Oct 19, 2026Market cap –P/E –Yield –
LFTD Partners profit margin
Profit margin (net margin) is net income as a percentage of revenue.
LFTD Partners's profit margin for the twelve months ending Mar 31, 2026 was -77.7%. For fiscal 2025 it was -67.3%, against -5.0% the year before. The highest annual figure on record is 18.3% in fiscal 2021.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -67.3% | −62.4 |
| FY2024 | Dec 31, 2024 | -5.0% | −9.2 |
| FY2023 | Dec 31, 2023 | 4.2% | −8.4 |
| FY2022 | Dec 31, 2022 | 12.5% | −5.8 |
| FY2021 | Dec 31, 2021 | 18.3% | +47.0 |
| FY2020 | Dec 31, 2020 | -28.7% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q1 FY2026 | Mar 31, 2026 | -45.4% | −42.1 |
| Q4 FY2025 | Dec 31, 2025 | -296.2% | −296.2 |
| Q3 FY2025 | Sep 30, 2025 | 7.0% | +9.2 |
| Q2 FY2025 | Jun 30, 2025 | -2.6% | −2.8 |
| Q1 FY2025 | Mar 31, 2025 | -3.3% | −8.0 |
| Q4 FY2024 | Dec 31, 2024 | 0.0% | −13.2 |
| Q3 FY2024 | Sep 30, 2024 | -2.2% | −1.1 |
| Q4 FY2023 | Dec 31, 2023 | 0.2% | −5.2 |
| Q3 FY2023 | Sep 30, 2023 | 4.7% | +0.9 |
| Q2 FY2023 | Jun 30, 2023 | 13.3% | −5.9 |
| Q1 FY2023 | Mar 31, 2023 | -1.1% | −17.4 |
| Q4 FY2022 | Dec 31, 2022 | 5.4% | −5.2 |
| Q3 FY2022 | Sep 30, 2022 | 3.8% | −21.6 |
| Q2 FY2022 | Jun 30, 2022 | 19.2% | −4.7 |
| Q1 FY2022 | Mar 31, 2022 | 16.3% | −2.2 |
| Q4 FY2021 | Dec 31, 2021 | 10.6% | −14.5 |
| Q3 FY2021 | Sep 30, 2021 | 25.4% | +19.0 |
| Q2 FY2021 | Jun 30, 2021 | 23.8% | +56.9 |
| Q1 FY2021 | Mar 31, 2021 | 18.4% | +493.7 |
| Q4 FY2020 | Dec 31, 2020 | 25.0% | – |
| Q3 FY2020 | Sep 30, 2020 | 6.3% | – |
| Q2 FY2020 | Jun 30, 2020 | -33.1% | – |
| Q1 FY2020 | Mar 31, 2020 | -475.3% | – |
See a number that looks wrong?